key: cord-0289951-57nhx9t9
authors: Meng, Bo; Datir, Rawlings; Choi, Jinwook; Bradley, John; Smith, Kenneth GC; Lee, Joo Hyeon; Gupta, Ravindra K.
title: SARS-CoV-2 Spike N-Terminal Domain modulates TMPRSS2-dependent viral entry and fusogenicity
date: 2022-05-10
journal: bioRxiv
DOI: 10.1101/2022.05.07.491004
sha: 871d4f82583d664fe1ca40bbe78a1b8d7003c69f
doc_id: 289951
cord_uid: 57nhx9t9

Over 20 mutations have been identified in the N-Terminal Domain (NTD) of SARS-CoV-2 spike and yet few of them are fully characterised. Here we first examined the contribution of the NTD to infection and cell-cell fusion by constructing different VOC-based chimeric spikes bearing B.1617 lineage (Delta and Kappa variants) NTDs and generating spike pseudotyped lentivirus (PV). We found the Delta NTD on a Kappa or WT background increased spike S1/S2 cleavage efficiency and virus entry, specifically in Calu-3 lung cells and airway organoids, through use of TMPRSS2. We have previously shown Delta spike confers rapid cell-cell fusion kinetics; here we show that increased fusogenicity can be conferred to WT and Kappa variant spikes by transfer of the Delta NTD. Moving to contemporary variants, we found that BA.2 had higher entry efficiency in a range of cell types as compared to BA.1. BA.2 showed higher fusogenic activity than BA.1, but the BA.2 NTD could not confer higher fusion to BA.1 spike. There was low efficiency of TMPRSS2 usage by both BA.1 and BA.2, and chimeras of Omicron BA.1 and BA.2 spikes with a Delta NTD did not result in more efficient use of TMRPSS2 or cell-cell fusogenicity. We conclude that the NTD allosterically modulates S1/S2 cleavage and spike-mediated functions such as entry and cell-cell fusion in a spike context dependent manner, and allosteric interactions may be lost when combining regions from more distantly related spike proteins. These data may explain the lack of successful SARS-CoV-2 inter-variant recombinants bearing breakpoints within spike.

The SARS-CoV-2 furin cleavage site (also known as a polybasic cleavage site), cleaved in producer 53 showed that the expression levels of chimeric spikes were comparable ( Figure 2A&B ). However, the 151 cleavage of spike in the chimeras phenocopied the cleavage patterns from which their NTD were 152 derived ( Figure 2C ). We extended this observation in WT chimeras where increased spike cleavage 153 was also evident following addition of either Kappa NTD or Delta NTD ( Figure S2B ). Structural data 154 indicate that the NTD, RBD and PBCS are cooperatively regulated (Gobeil et al., 2021) . Hence we 155 reasoned that the observed increase in the accessibility to the furin cleavage site may be regulated 156 by the allostery involving the NTD. 157 SARS-CoV-2 primarily enters Calu-3 cells through membrane fusion due to an abundant expression 158 of TMPRSS2 and ACE2 at the plasma membrane. The primary cleavage at S1/S2 is a prerequisite for a 159 secondary cleavage at S2' site by proteases such as TMPRSS2 at the plasma membrane (V'kovski et 160 al., 2021), triggering the conformational rearrangement of S2 for the exposure of the fusion peptide. 161

Due to more efficient cleavage of the Delta spike ( Figure S1 ), we reasoned that the Delta spike may 162 be more efficiently primed to use TMPRSS2 at the plasma membrane for its entry. To test this 163 hypothesis, we transduced the virus bearing either authentic spike of Delta or Kappa or their NTD-164 chimeric counterparts into TMPRSS2 overexpressing 293T cells or parental 293T cells ( Figure 2D ). As 165 expected, all the viruses including chimeras increased entry efficiency when TMPRSS2 was present 166 with an even more pronounced increase observed in Delta, consistent with the observation that 167

Delta is more efficient in utilising TMPRSS2. Intriguingly, we also observed an increased transduction 168 efficiency for the Kappa chimera that was comparable to that of Delta, suggesting that the Delta NTD 169 enables the entry of chimeric Kappa by efficient TMPRSS2 usage. Consistent with this model, the 170 ratio of entry for the Delta chimera containing Kappa NTD entry in TMPRSS2 overexpressing cells 171 versus normal expressing cells was reduced. 172 173 To further investigate the dependence of TMPRSS2 on virus entry, we pretreated A549-174 ACE2/TMPRSS2 cells or airway organoids with either camostat (a TMPRSS2 inhibitor) or E64D (a 175 cathepsin inhibitor). We observed that the IC50 of camostat in Delta was approximately 2 fold higher 176 than Kappa, whilst E46D had little effect on either virus ( Figure 2E ). Reassuringly, a similar 177 observation was made in airway organoids ( Figure 2F ), suggesting that Delta is more resistant to 178 camostat and hence is more efficient in utilising available TMPRSS2 for virus entry. Indeed the Kappa 179 chimera bearing Delta NTD showed a similar drug sensitivity profile to Delta implying that the NTD is 180 accountable for this shift in TMPRSS2 sensitivity ( Figure 3S ). 181

It is reported that the NTD modulates RBD conformation through allosteric effects (Qing et al., 182 2021) . We speculated the accessibility to ACE2 is altered in the chimeric spikes. We next went on to examine this by transducing parental 293T cells or their isogenic counterparts where the expression 184 of TMPRSS2 is abrogated and ACE2 is overexpressed (A2delT2). Indeed, we found a 30 fold increase 185 in Delta when ACE2 is overexpressed whereas Kappa only had 4 fold increase ( Figure 4G ). More 186 strikingly, the Kappa chimera, bearing the Delta NTD in the Kappa spike backbone, showed a similar 187 magnitude of increase as Delta. Conversely, the Delta chimera bearing a Kappa NTD manifested a 188 decrease in ACE2 dependence compared to Delta, albeit to a lesser extent. Taken together, our data 189 support the notion that the Delta NTD modulates the use of TMPRSS2 more efficiently due to spike 190 cleavage and that the Delta NTD allosterically regulates the RBD to increase efficiency of ACE2 usage. 191

To probe the mutations in the Delta NTD that may contribute to the enhanced infectivity in Calu3 193 cells, we constructed a series of spike bearing PV by reverting a cluster of amino acids (142D, 156G, 194 del157F and del158R) to WT Wuhan-1 residues individually. Interestingly, each individually reverted 195 mutant showed a decrease in infectivity in Calu3 cells with the greatest reduction seen following re-196 insertion of the deleted 157R/158R (3 fold). This is in agreement with the infectivity reduction in the 197 Delta NTD bearing Kappa chimera ( Figure 1B To test this, PV were harvested and used to transduce HeLa-ACE2 cells in the presence of a dilution 203 series of vaccine sera from vaccinees who had received two doses of BNT162b2 at least 1 month 204 prior to sampling. D142G alone did not alter the sensitivity of neutralisation ( Figure 3 ). However, 205 G156E or repairing the deletion of 157F/158R increased the sensitivity of neutralization by 2 fold, 206 consistent with the notion that the NTD is important for immune evasion and infectivity. largely correlates with fusion and we observed an enhanced cleavage in the Kappa chimera, we 214 sought to examine whether spike mediated fusion is altered. We first confirmed that efficient 215 cleavage is required for the syncytia formation as the mutants bearing the WT proline at position 216 681 (681P) decreased fusion efficiency in both parental and chimeras whereas the mutation to 217 histidine (681H), the other cleavage site mutation firstly found in Alpha and then in Omicron, did not 218 ( Figure 4B ). We then went on to explore whether or not the fusogenicity is different between Delta 219 and Kappa and their chimeras. Concordant with the published studies we found a marked increase in 220 fusion for Delta and Kappa compared to WT ( Figure 4C ) (Mlcochova et al., 2021; Rajah et al., 2021) . 221

Unexpectedly, we found the fusion kinetics between Delta and Kappa were noticeably different 222 despite manifesting a comparably maximal fusion activity at the steady-state (around 70%; Figure  223 3C). More specifically, Delta was more fusogenic at earlier time points whereas Kappa required two 224 more hours to reach a similar intensity. Intriguingly when the Kappa NTD was fused into Delta the 225 fusion phenotype shifted from Delta to Kappa, with a slowing of kinetics ( Figure 3C ). Conversely, we 226 observed a fast-fusing Delta phenotype when the Delta NTD was swapped into Kappa. Of note, we 227 also observed a faster fusion phenotype when the Delta NTD was fused into the WT backbone, 228 though this effect was less pronounced compared to that observed in the Kappa chimera ( Figure 4C ). 229

Taken together we have demonstrated that the Delta NTD can drive faster fusion in both WT and 230

Kappa spike backgrounds. 231

Epidemiological studies suggest that the more recent Omicron (BA.1 and BA.2) variants are distantly 232 related to all the other early pandemic variants (Simon-Loriere and Schwartz, 2022). It therefore 233 remains possible that the ability of the Delta NTD to drive faster fusion is dependent on their spike 234 background. We found that in comparison to BA.1 BA.2 was more efficient in entering Calu3 cells, 235 though still not as efficient as Delta ( Figure 5A ). An elevated level of entry of BA.2 over BA.1 was 236 observed in H1299 cells where the entry of Delta was the least efficient. These data suggest that 237 BA.2 is capable of infecting both TMPRSS2 low (H1299) and high (Calu3) cells efficiently. 238

We then introduced the Delta NTD into the both BA.1 and BA.2 to examine whether the Delta NTD 239 could also confer increased fusion to Omicron, a known poor cell-cell fusion spike ( Figure 5B ). 240

Although BA.2 showed faster fusion than BA.1, consistent with a recently published study (Yamasoba 241 et al., 2022), both Omicron and the Delta-NTD fused Omicron chimeras showed poor spike-mediated 242 fusion and that most importantly the difference between Omicron and its counterpart was 243 negligible. Intriguingly, this phenotype correlates with inefficient cleavage of spike even after the 244 cleavage-enhancing Delta NTD was fused into an Omicron spike background. 245

Omicron has evolved to avoid the early entry route via TMPRSS2 at the plasma membrane by 246 entering the cells through endosomal route (Meng et al., 2022) . Given spike cleavage was not 247 affected by domain swapping, we predicted that the Omicron chimera bearing the Delta NTD would 248 fail to confer increased sensitivity to TMPRSS2, in contrast to our findings for the B.1.617 lineages Delta and Kappa. Indeed there was only a moderate increase in entry (2-3 fold) when TMPRSS2 was 250 overexpressed, compared to 9 fold for Delta, reinforcing the notion that the virus entry of Omicron 251 is TMPRSS2 independent and that altering the NTD is not sufficient to confer TMPRSS2 usage to 252

Omicron. 253

We next sought to examine whether the BA. The NTD has been proposed to modulate the RBD to a receptor accessible mode (Qing et al., 2021) . 276

We speculated that by alternating the NTD of Delta into Kappa the receptor engagement with ACE2 277 is affected. Indeed we observed an enhanced virus entry in the Kappa chimera bearing the Delta 278 NTD ( Figure 2G ). However an increased accessibility to ACE2 cannot solely account for the enhanced 279 infectivity observed in Calu3 as such an increase is not evident for the cell lines where ACE2 is also 280 abundantly expressed. A marked increase for chimeric Kappa spike to use TMPRSS2 at the plasma 281 membrane provides a plausible explanation for this specificity; the chimeric Kappa spike is as 282 efficient as Delta on TMPRSS2 usage ( Figure 2D ). This observation is in agreement with our inhibitor 283 experiment, whereby the addition of the TMPRSS2 protease inhibitor camostat has a more 284 pronounced inhibitory effect for Kappa than Delta ( Figure 2E&F ). However, the Delta NTD cannot 285 enhance the cleavage of Omicron spike nor its dependence on TMPRSS2 ( Figure 5B&C have proposed that the sensitivity to TMPRSS2 correlates with cleavage status at S1/S2, which has 294 an additional impact on the cell to cell fusion (Meng et al., 2022) . Consistent with this notion, we 295 found the Delta NTD confers faster fusion kinetics in both WT and Kappa which coincides with an 296 elevated S1/S2 cleavage in WT and Kappa spike bearing the Delta NTD. However S1/S2 cleavage is 297 unaltered in the Delta NTD bearing Omicron which also has poor fusogenicity. These data 298 demonstrated that regions other than NTD may also be required for efficient cleavage. Indeed a 299 recent study using a domain swapping approach has suggested the RBD of Omicron contributes to 300 inefficient spike cleavage and inferior fusogenicity (doi.org/10.1101/2022.04.03.486864). The 301 specific site in S2 preceding to fusion peptide has also been implicated in facilitating an efficient 302 cleavage in accordance with the NTD (Qing et al., 2022) . 303

We observed that the Kappa spike is less stable than that of Delta ( Figure S1C ). We suspect that 304 when Delta first emerged with the RBD mutations the intermediate strain was less fit leading to a 305 premature S1 shedding. However, the subsequently acquired mutations in the NTD allosterically 306 foster non-covalent interactions between S1 and S2 forming more stabilised protomers before 307 engagement with ACE2. This process ultimately leads to active S1 shedding and exposure of the 308 fusion peptide. D614G emerged as a positively selected mutation in an early stage of the pandemic 309 persisting in subsequent lineages by stabilising trimeric spike. The more stable form of S1 is interactions to prevent S1 from being loosened prematurely while bolstering the RBD in an ACE2-314 accessible form. 315

Finally we showed that Delta NTD revertant mutations (G156E and 157F/158R repair) were able to 316 compromise cell entry and increase sensitivity to neutralisation by vaccine sera. Reassuringly, a 317 similar finding was recently reported in breakthrough B.1.617 viruses where the same mutations in 318 the NTD accounted for the attenuated neutralisation sensitivity (Mishra et al., 2022) . 319

In summary, our data support the cooperativity between NTD, RBD and the furin cleavage site. We 320 propose that the NTD allosterically affects the conformation of the RBD for ACE2 binding and the and 293T-GFP11 have been described previously (Papa et al., 2021) . All the 293T cell lines as well as 362

Vero-GFP1-10 were maintained in DMEM with 10% FBS and 1% PS. All cells were regularly tested 363

and are mycoplasma free. Airway epithelial organoids were obtained and maintained as previously 364

described (Meng et The SARS-CoV2 spike-pseudotyped viruses containing supernatants were standardised using a SYBR 392

Green-based product-enhanced PCR assay (SG-PERT) as described previously (Pizzato et al., 2009 ). 393

Briefly, 10-fold dilutions of virus supernatant were lysed in a 1:1 ratio in a 2x lysis solution (made up  394 of 40% glycerol v/v 0.25% Triton X-100 v/v 100mM KCl, RNase inhibitor 0.8 U/ml, TrisHCL 100mM, 395 buffered to pH7.4) for 10 minutes at room temperature. Sample lysates (12 μl) were added to 13 μl 396 of SYBR Green master mix (containing 0.5μM of MS2-RNA Fwd and Rev primers, 3.5pmol/ml of MS2-397 RNA, and 0.125U/μl of Ribolock RNAse inhibitor and cycled in a QuantStudio (Thermofisher). 398

Relative amounts of reverse transcriptase activity were determined as the rate of transcription of 399 bacteriophage MS2 RNA, with absolute RT activity calculated by comparing the relative 400 amounts of RT to an RT standard of known activity. 401 402

Western blot 403

For cell lysates, 293 cells were washed and lysed in lysis buffer (Cell Signalling) 404

and lysates were diluted with 4 × sample buffer (Biorad) and boiled for 10 m before 405 subjected to western blotting. For virion purification, clarified supernatants were loaded onto a thin 406 layer of 8.4% optiprep density gradient medium (Sigma-Aldrich) and placed in a TLA55 rotor 407 (Beckman Coulter) for ultracentrifugation for 2 hours at 20,000 rpm. The pellet was then 408 resuspended for western blotting. For protein detection, the following antibodies were used: 409 rabbit anti-SARS-CoV-2 S monoclonal antibody (PA1-41165; Thermofisher), mouse anti-410 SARS-CoV-2 S1 (MAB105403, R&D systems), rabbit anti-GAPDH polyclonal antibody (10494-1-AP; 411

Proteintech), horseradish peroxidase (HRP)-conjugated anti-rabbit and anti-mouse IgG polyclonal 412 antibody (Cell Signalling). Chemiluminescence was detected using ChemiDoc Touch Imaging System 413 (Bio-Rad). The cleavage ratio of S1 or S2 to FL in virions was determined by densitometry using 414 ImageJ (NIH). 415 416

Drug assay 417 A549-ACE2-TMPRSS2 (A549-A2T2) cells or human airway organoids were either E64D (Tocris) or 418 camostat (Sigma-Aldrich) treated for 2 hours at each drug concentration before the addition of a 419 comparable amount of input viruses pseudotyped with Delta, Kappa or chimeras (approx. 100,000 420 RLU). The cells were then left for 48 hours before the addition of substrate for luciferase 421 (Promega) and read on a Glomax plate reader (Promega). The RLU was normalised against the no-422 drug control which was set as 100%. 423 424

Cell-cell fusion assay 425

Cell-cell fusion assays were described previously (Meng et al., 2022) . Briefly, 293T GFP11 and Vero-426 GFP1-10 cells were seeded at 80% confluence in a 1:1 ratio in 48 multiwell plate the day before. 427

Cells were co-transfected with 250 ng of spike expression plasmids using Fugene 428 6 following the manufacturer's instructions (Promega). Cell-cell fusion was measured using 429

an Incucyte and determined as the proportion of green area to total phase area over time. Data 430 were normalised to non-transfected control. Graphs were generated using Prism 9 software. 431 432

Neutralisation assay 433

This was performed as previously described (Collier et al., 2021b (Collier et al., , 2021a . The intensity of the spike-associated bands on the western blots was densitometrically quantified (ImageJ) before the ratio was calculated for cleavage (S2/FL, paired t test.) (B) or spike stability (S1/S2; one sample t test) (C). In both (B) and (C) each dot represents one PV preparation. (D): A representative western blot of the purified PVs bearing RBD mutations only in Kappa and Kappa spike, together with WT and non-spike control. *p<0.05. 

Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 438 receptor on binding affinity and kinetics

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 441 spike-induced syncytia

Syncytia formation by SARS-CoV-2-infected 444 cells

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain 447 target a single supersite

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited 454 antibodies

Age-related immune response heterogeneity to SARS-CoV-2 457 vaccine BNT162b2

The spike d614g mutation increases sars-cov-2 infection of multiple human cell types

Genomic characterization and epidemiology of an emerging 463 SARS-CoV-2 variant in Delhi

Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike

SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not 470 Synergistic for Antibody Evasion

D614G Mutation Alters SARS-CoV-2 Spike Conformation 474 and Enhances Protease Cleavage at the S1/S2 Junction

A Multibasic Cleavage Site in the Spike 477 Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

SARS-CoV-2 Cell Entry Depends on ACE2 and 481 TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Mechanisms of SARS-CoV-2 entry into cells

Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. 487

SARS-CoV-2 evolution during treatment of chronic 490 infection

Lectins enhance SARS-CoV-2 infection and influence neutralizing 493 antibodies

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and 496 neutralizing antibodies

An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by 499 antibodies

The N501Y spike substitution enhances SARS-CoV-2 infection and transmission

Molecular basis of immune evasion by the Delta and Kappa 505 SARS-CoV-2 variants

N-terminal domain antigenic mapping reveals a site of 508 vulnerability for SARS-CoV-2

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody 511 escape

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 514 and its role in the Alpha variant B.1.1.7

Altered TMPRSS2 usage by SARS-CoV-2 Omicron 518 impacts infectivity and fusogenicity

SARS-CoV-2 spike E156G/Δ157-158 mutations contribute to increased infectivity and immune 522 escape

Combined Point-of-Care Nucleic Acid and Antibody 525 Testing for SARS-CoV-2 following Emergence of D614G Spike Variant

SARS-CoV-2 B.1.617.2 Delta variant replication and immune 529 evasion

Hydroxychloroquine-mediated 531 inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2

Hydroxychloroquine-mediated 534 inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2

Furin cleavage of SARS-CoV-2 Spike promotes but is not 538 essential for infection and cell-cell fusion

Proteolytic 541 processing of middle east respiratory syndrome coronavirus spikes expands virus tropism

The furin cleavage site in the SARS-CoV-2 spike protein 545 is required for transmission in ferrets

Cell entry by SARS-CoV-2. Trends in 548

Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in 551 cell culture supernatants

Dynamics of sars-cov-2 spike proteins in cell entry: Control elements in the amino-terminal domains

Inter-557 domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry

SARS-CoV-2 Alpha, Beta, and Delta variants display 561 enhanced Spike-mediated syncytia formation

SARS-CoV-2 B.1.1.7 and B.1.351 564 spike variants bind human ACE2 with increased affinity

Structural and biochemical rationale for enhanced spike protein 568 fitness in delta and kappa SARS-CoV-2 variants

Towards SARS-CoV-2 serotypes?

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by 574 convalescent and vaccine sera

Neutralizing and protective human monoclonal 577 antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. 581

Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta. 584

Coronavirus biology and 586 replication: implications for SARS-CoV-2

Coronavirus entry: how we arrived at SARS-CoV-2

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to 595 SARS-CoV-2

Structural and Functional Analysis of the

CoV-2 Spike Protein Variant

Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta 601 variant

Structural impact on SARS-CoV-2 spike protein by D614G substitution

SARS-CoV-2 spike-protein D614G mutation increases 607 virion spike density and infectivity